Evaluating the Safety and Efficacy of Concizumab in Hemophilia A/B Patients: A Systematic Review
Background Hemophilia A and B are X-linked recessive bleeding disorders caused by deficiencies of coagulation factors VIII and IX, respectively. These conditions lead to spontaneous bleeding, joint damage, inhibitor development, and the burden of frequent intravenous infusions. Concizumab, a monoclo...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
SAGE Publishing
2025-05-01
|
| Цуврал: | Clinical and Applied Thrombosis/Hemostasis |
| Онлайн хандалт: | https://doi.org/10.1177/10760296251342968 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|